CDC approves COVID-19 vaccine for children under 5
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On June 18, the U.S. Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 6 months to 5 years old, following a recommendation from the Food and Drug Administration (FDA). This approval now expands vaccine eligibility for the use of the two primary COVID-19 vaccines in the U.S. – Pfizer-BioNTech and Moderna – to nearly 20 million additional children, and makes all Americans aged 6 months and older eligible to receive a COVID-19 vaccination.
The White House has indicated that the federal government has an initial supply of approximately 10 million doses of pediatric vaccines, for which states began placing orders last month. CDC has indicated that the distribution of pediatric vaccinations for children aged 5 and under has already begun and shots will be available at local pediatric practices, pharmacies, Federally Qualified Health Centers, local health departments, clinics and other locations as early as June 20. Earlier this month, the agency updated it’s Pediatric COVID-19 Vaccination Operational Planning Guide with information on dosage ordering and a pediatric readiness checklist for local distribution.
As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of nearly 600 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
Additional Resources
Resource
The County Role in Vaccines
Related News
County Leaders Visit Washington to Share Local Perspective on Budget Reconciliation
Elected officials from five states sound alarm about administrative and funding changes to SNAP and Medicaid.
U.S. House reintroduces legislation to address the Medicaid Inmate Exclusion Policy with NACo support
Two bipartisan bills aimed at addressing the Medicaid Inmate Exclusion Policy (MIEP) were recently reintroduced in the U.S. House of Representatives.
U.S. House of Representatives re-establishes Bipartisan Mental Health Caucus with NACo support
On May 7, members of the U.S. House of Representatives appointed new leadership to the Bipartisan Mental Health Caucus, reaffirming their commitment to addressing the nation’s mental health crisis through cross-party collaboration.